Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Interactive Journal of Medical Research|January 10, 2016
Designing an Electronic Patient Management System for Multiple Sclerosis: Building a Next Generation Multiple Sclerosis Documentation SystemRaimar Kern, Rocco Haase, Judith Christina Eisele, et al.Neurology(R) Neuroimmunology & Neuroinflammation|May 24, 2016
Acute effects of alemtuzumab infusion in patients with active relapsing-remitting MSKatja Thomas, Judith Eisele, Francisco Alejandro Rodriguez-Leal, et al.Plos One|April 25, 2013
Cortisol awakening response is linked to disease course and progression in multiple sclerosisSimone Kern, Ivonne Krause, Antje Horntrich, et al.BMC Neurology|July 20, 2016
Rationale, design, and methods of a non-interventional study to establish safety, effectiveness, quality of life, cognition, health-related and work capacity data on Alemtuzumab in multiple sclerosis patients in Germany (TREAT-MS)Tjalf Ziemssen, Ulrich Engelmann, Sigbert Jahn, et al.Journal of Neuroinflammation|February 25, 2017
Fingolimod additionally acts as immunomodulator focused on the innate immune system beyond its prominent effects on lymphocyte recirculationKatja Thomas, Tony Sehr, Undine Proschmann, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|June 4, 2013
Multiple sclerosis documentation system (MSDS): moving from documentation to management of MS patientsTjalf Ziemssen, Raimar Kempcke, Marco Eulitz, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|July 26, 2017
Fampridine response in MS patients with gait impairment in a real-world setting: Need for new response criteria?Francisco Alejandro Rodriguez-Leal, Rocco Haase, Katja Thomas, et al.Neurology(R) Neuroimmunology & Neuroinflammation|October 24, 2014
Accumulation and therapeutic modulation of 6-sulfo LacNAc(+) dendritic cells in multiple sclerosisKatja Thomas, Kristin Dietze, Rebekka Wehner, et al.Journal of Neuroinflammation|September 2, 2017
Safety and in vivo immune assessment of escalating doses of oral laquinimod in patients with RRMSTjalf Ziemssen, Hayrettin Tumani, Tony Sehr, et al.Pageof 2